CH629799A5 - Verfahren zur herstellung von amiden der pseudomonsaeure. - Google Patents

Verfahren zur herstellung von amiden der pseudomonsaeure. Download PDF

Info

Publication number
CH629799A5
CH629799A5 CH209177A CH209177A CH629799A5 CH 629799 A5 CH629799 A5 CH 629799A5 CH 209177 A CH209177 A CH 209177A CH 209177 A CH209177 A CH 209177A CH 629799 A5 CH629799 A5 CH 629799A5
Authority
CH
Switzerland
Prior art keywords
pseudomonic acid
formula
acid
amides
compounds
Prior art date
Application number
CH209177A
Other languages
German (de)
English (en)
Inventor
Norman Harold Rogers
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of CH629799A5 publication Critical patent/CH629799A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CH209177A 1976-02-20 1977-02-18 Verfahren zur herstellung von amiden der pseudomonsaeure. CH629799A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6884/76A GB1565083A (en) 1976-02-20 1976-02-20 Pseudomonic acid amides

Publications (1)

Publication Number Publication Date
CH629799A5 true CH629799A5 (de) 1982-05-14

Family

ID=9822555

Family Applications (1)

Application Number Title Priority Date Filing Date
CH209177A CH629799A5 (de) 1976-02-20 1977-02-18 Verfahren zur herstellung von amiden der pseudomonsaeure.

Country Status (12)

Country Link
US (1) US4139629A (enExample)
JP (1) JPS52102279A (enExample)
BE (1) BE851410A (enExample)
CH (1) CH629799A5 (enExample)
DE (1) DE2706548A1 (enExample)
DK (1) DK145823C (enExample)
FR (1) FR2349584A1 (enExample)
GB (1) GB1565083A (enExample)
IE (1) IE44445B1 (enExample)
NL (1) NL7701727A (enExample)
SE (1) SE431649B (enExample)
ZA (1) ZA77772B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
CA1103264A (en) * 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
EP0001914B1 (en) * 1977-11-05 1981-05-20 Beecham Group Plc Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides
US4297365A (en) * 1978-08-04 1981-10-27 Ciba-Geigy Corporation Benzimidazoles and pharmaceutical preparations containing such compounds
EP0026611B1 (en) * 1979-09-28 1984-02-01 Beecham Group Plc Antibacterial sulphonamides, processes for their preparation and compositions containing them
US5292892A (en) * 1991-05-07 1994-03-08 Sankyo Company, Limited Anti-bacterial compound and pharmaceutical compositions thereof
JP3038064B2 (ja) * 1991-10-07 2000-05-08 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
IL107017A (en) * 1992-09-18 1998-01-04 Sankyo Co Thiomarinol derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483227A (en) * 1966-06-03 1969-12-09 Merck & Co Inc 2,5 - disubstituted - 2 - (carboxyalkoxyaroyl) - 6 - (carboxyalkoxyaryl)-3,4-dihydro-2h-pyrans and their derivatives
US3740437A (en) * 1970-06-25 1973-06-19 Syntex Corp Naphthyloxyacetic acids and pharmaceutical compositions and methods thereof
US3755603A (en) * 1970-07-01 1973-08-28 Syntex Corp Biphenylyloxyacetic acids in pharmaceutical compositions
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics

Also Published As

Publication number Publication date
DK145823B (da) 1983-03-14
FR2349584A1 (fr) 1977-11-25
ZA77772B (en) 1977-12-28
IE44445L (en) 1977-08-20
BE851410A (fr) 1977-08-16
SE431649B (sv) 1984-02-20
NL7701727A (nl) 1977-08-23
SE7701722L (sv) 1977-08-21
DE2706548A1 (de) 1977-08-25
DK73777A (da) 1977-08-21
JPS52102279A (en) 1977-08-27
DK145823C (da) 1983-08-29
GB1565083A (en) 1980-04-16
IE44445B1 (en) 1981-12-02
US4139629A (en) 1979-02-13
FR2349584B1 (enExample) 1980-03-21

Similar Documents

Publication Publication Date Title
DE3037102C2 (de) (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylat-pentahydrat
DD145059A5 (de) Verfahren zur herstellung einer antibakteriellen zusammensetzung
DE2726618C2 (enExample)
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
CH657853A5 (de) Carbapenemderivate, deren herstellung und solche verbindungen enthaltende praeparate.
DE2742949A1 (de) 4-n-acylfortimicin b-derivate
CH646978A5 (de) Verfahren zur herstellung neuer hydroxylamin-substituierter aliphatischer phosphonsaeuren.
DE1795188B2 (de) 3-Alkoxymethylcephalosporine, Verfahren zu deren Herstellung und die diese enthaltenden pharmazeutischen Zusammensetzungen
CH629799A5 (de) Verfahren zur herstellung von amiden der pseudomonsaeure.
DE2221912A1 (de) Penicillinester,deren Salze und Verfahren zu ihrer Herstellung
DE2804508C2 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung als antibakterielle Wirkstoffe
DE69004143T2 (de) 6-Fluorshikiminsäurederivate.
DE2312041A1 (de) Penicilline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE3317742C2 (enExample)
EP0400499B1 (de) Neue Acylaminosäurederivate enthaltende Arzneimittel und Diätetika
CH640236A5 (en) 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2 -carboxylic acid and process for its preparation
DE69909098T2 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
DE69131774T2 (de) Antibakterielle penem-ester derivate
CH630921A5 (de) Verfahren zur herstellung neuer penicillin-derivate.
DD210054A5 (de) Verfahren zur herstellung neuer derivate des cephalosporin
DD248592A5 (de) Verfahren zur herstellung der [3s(z)]-2-[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfoxy)-3-azetidinyl]-amino]-2-oxoaethyliden]-aminooxyessigsaeure und ihrer salze
CH671020A5 (enExample)
DE2754323C2 (enExample)
DE2652675A1 (de) N-acylderivate von thienamycin, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH669381A5 (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased